Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bridgebio Oncology Therapeutics, Inc. (BBOT) since 2024 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bridgebio Oncology Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1869105.
Total stock buying since 2024: $24,000,000.
Total stock sales since 2024: $0.
Total stock option exercises since 2024: $0.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 0 | $0 | 0 | $0 | 4,262,126 | $0 |
2024 | 2,400,000 | $24,000,000 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-08 | 0 | $0 | 0 | $0 | 4,262,126 | $0 |
2024-02 | 2,400,000 | $24,000,000 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-08-11 | Holman Albert A Iii | Option Ex | 30,000 | .00 | 0 |
2025-08-11 | Mckenna Mark C. | Option Ex | 30,000 | .00 | 0 |
2025-08-11 | Chen Bihua | Option Ex | 4,172,126 | .00 | 0 |
2025-08-11 | Schmid John P. | Option Ex | 30,000 | .00 | 0 |
2024-02-13 | Chen Bihua (CEO and Chairperson) | Buy | 2,400,000 | 10.00 | 24,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of BBOT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bridgebio Oncology Therapeutics, Inc. (symbol BBOT, CIK number 1869105) see the Securities and Exchange Commission (SEC) website.